Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
XB-PHENO-22628

Xla Wt + fgfr1, Shifley ET et al. (2012)

Experiment + Assay: Xla Wt + fgfr1 + NF23 (immunohistochemistry)
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
mRNA injection fgfr1.L fgfr1.L
 NF stage 5 (16-cell) blastomere D2.1
Conditions:
Assay Type Assay Stages Antibody
immunohistochemistry NF stage 23  
Expression Phenotypes (2):
decreased amount mapk1.L expression in endoderm
decreased amount mapk1.L expression in foregut
Source: Fig 4A
Article: XB-ART-45962, PubMed